缩写名/全名 |
IMMUNOPHARM IMMUNOT
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY |
||||||||||||||||||||||||||||
ISSN号 | 0892-3973 | ||||||||||||||||||||||||||||
研究方向 | 医学-毒理学 | ||||||||||||||||||||||||||||
影响因子 | 2015:1.617, 2016:1.475, 2017:2.024, 2018:2.086, 2019:2.352, | ||||||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||||||
出版周期 | Quarterly | ||||||||||||||||||||||||||||
年文章数 | 78 | ||||||||||||||||||||||||||||
出版年份 | 0 | ||||||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||||||
审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||||||||||
录用比例 | 容易 | ||||||||||||||||||||||||||||
投稿链接 | http://mc.manuscriptcentral.com/lipi | ||||||||||||||||||||||||||||
投稿官网 | http://www.tandfonline.com/toc/iipi20/current | ||||||||||||||||||||||||||||
h-index | 42 | ||||||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0892-3973%5BISSN%5D | ||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Inhibition of LPS-induced brain injury by NR2B antagonists through reducing assembly of NR2B-CaMKII-PSD95 signal module. Author: Song Y1,2, Zhao X3, Wang D3, Zheng Y1,4, Dai C3, Guo M3, Qin L3, Wen X2, Zhou X5, Liu Z6. Journal: Immunopharmacol Immunotoxicol. 2019 Jan 3:1-9. doi: 10.1080/08923973.2018.1549566. [Epub ahead of print] PubMed DOI |
2. | Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients. Author: Zeng Q1, Yuan XY2, Li W3, Liu BW1, Zhao X1, Ren GJ1, Wang Y1, Dou J1, Wang GY4. Journal: Immunopharmacol Immunotoxicol. 2019 Jan 11:1-6. doi: 10.1080/08923973.2018.1533026. [Epub ahead of print] PubMed DOI |
3. | Sclareol attenuates the development of atopic dermatitis induced by 2,4-dinitrochlorobenzene in mice. Author: Wu PC1, Chuo WH2, Lin SC3, Lehman CW3, Lien CZ4, Wu CS5, Lin CC6,7. Journal: Immunopharmacol Immunotoxicol. 2019 Feb 1:1-8. doi: 10.1080/08923973.2018.1555846. [Epub ahead of print] PubMed DOI |
4. | The antagonistic effect of tamoxifen against d-galactosamine/lipopolysaccharide-induced acute liver failure is associated with reactivation of hepatic nuclear factor-κB. Author: Liu L1, Zhao Y2, Lin Y1, Zhang R1, Luo S1, Ye P1, Luo M1. Journal: Immunopharmacol Immunotoxicol. 2019 Feb 5:1-7. doi: 10.1080/08923973.2019.1569044. [Epub ahead of print] PubMed DOI |
5. | Phillygenin exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes. Author: Du B1,2,3, Zhang L1, Sun Y1, Zhang G1,2, Yao J1,2,3, Jiang M1,2,3, Pan L1,2,3, Sun C1,2,3. Journal: Immunopharmacol Immunotoxicol. 2019 Feb 5:1-10. doi: 10.1080/08923973.2018.1547742. [Epub ahead of print] PubMed DOI |
6. | Dehydroxymethylepoxyquinomicin suppresses atopic dermatitis-like lesions in a stratum corneum-removed murine model through NF-κB inhibition. Author: Jiang X1, He H1, Xie Z1, Wen H1, Li X1, Li X1, Ma J2, Umezawa K3, Zhang Y1. Journal: Immunopharmacol Immunotoxicol. 2019 Feb 6:1-8. doi: 10.1080/08923973.2018.1510962. [Epub ahead of print] PubMed DOI |
7. | Silica nanoparticles as an enhancer in the IL-1β-induced inflammation cycle of A549 cells. Author: Wu J1,2, Han Y1,2, Zou X1,2, Zhu K1,2, Wang Z2, Ye X1,2, Liu Y1,2, Dong S1,2, Chen X1,2, Liu D2, Wen Z2, Wang Y2, Huang S2, Zhou Z2, Zeng C2, Huang C2, Zheng S2, Du X2, Huang X2, Zhang B1, Jing C2,3, Yang G1,3. Journal: Immunopharmacol Immunotoxicol. 2019 Feb 6:1-8. doi: 10.1080/08923973.2019.1569046. [Epub ahead of print] PubMed DOI |
8. | Inhibition of tumor necrosis factor alpha and increased of interleukin 10 by Lactobacillus: a molecular mechanism protection against TNBS-induced ulcerative colitis in chicks. Author: Jing L1, Yu Z1, Gao X1, Liu C1, Lv X1, Zheng S1. Journal: Immunopharmacol Immunotoxicol. 2019 Mar 1:1-6. doi: 10.1080/08923973.2019.1566360. [Epub ahead of print] PubMed DOI |
9. | Sinomenine regulates CD14/TLR4, JAK2/STAT3 pathway and calcium signal via α7nAChR to inhibit inflammation in LPS-stimulated macrophages. Author: Zhu RL1, Zhi YK1, Yi L1, Luo JF2, Li J1, Bai SS1, Liu L2, Wang PX1, Zhou H2,3, Dong Y1. Journal: Immunopharmacol Immunotoxicol. 2019 Mar 21:1-6. doi: 10.1080/08923973.2019.1568451. [Epub ahead of print] PubMed DOI |
10. | A comparative evaluation of the immunotoxicity and immunomodulatory effects on macrophages exposed to aromatic trihalogenated DBPs. Author: Xie Y1, Jiang L2, Qiu J1, Wang Y1,3. Journal: Immunopharmacol Immunotoxicol. 2019 May 3:1-8. doi: 10.1080/08923973.2019.1608444. [Epub ahead of print] PubMed DOI |
|
|